Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population-Reference-Cited by-同舟云学术

Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population

Published:2014-10-20 Issue:10 Volume:9 Page:e110691
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Friedrich Deise C.,Genro Júlia P.,Sortica Vinicius A.,Suarez-Kurtz Guilherme,de Moraes Maria Elizabete,Pena Sergio D. J.,dos Santos Ândrea K. Ribeiro,Romano-Silva Marco A.,Hutz Mara H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy;M Ingelman-Sundberg;Philos Trans R Soc Lond B Biol Sci,2005

2. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants;LD Bradford;Pharmacogenomics,2002

3. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response;J Kirchheiner;Mol Psychiatry,2004

4. Pharmacogenomics and individualized drug therapy;M Eichelbaum;Annu Rev Med,2006

5. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet;SF Zhou,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine;Heliyon;2024-04

3. CYP2D6 genotyping and the clinical impact on outcomes in breast cancer tamoxifen-treated patients;Personalized Medicine;2023-11

4. Distribution of pharmacogene allele and phenotype frequencies in Brazilian psychiatric patients;Pharmacogenomics;2023-10-17

5. Influence of polymorphisms in CYP2C9, VKORC1, MDR1 and APOE genes on the warfarin maintenance dose in Brazilian patients;Pharmacogenomics;2023-08